A major advance in cancer research is emerging with the use of mini-antibodies to reactivate dysfunctional p53. This crucial malignant suppressor protein is frequently disabled in many types of malignancies, causing https://hyperbookmarks.com/story21925650/mini-antibodies-restore-tumor-suppressor-p53-the-new-hope-for-tumor-therapy